Capecitabine combined with oxaliplatin (XELOX) as first line chemotherapy in colorectal cancer with liver metastases

被引：0
|
作者：
Mahfouf, H.
Djedi, H.
Oukkal, M.
Bouzid, K.
Bentabak, K.
Graba, A.
Chaher, N.
Ait, Kaci N.
Terki, N.
机构：
[1] EHS Ctr Pierre & Marie Curie, Dept Med Oncol, Algiers, Algeria
[2] EHS Ctr Pierre & Marie Curie, Dept Surg, Algiers, Algeria
[3] EHS Ctr Pierre & Marie Curie, Dept Pathol, Algiers, Algeria
来源：
ANNALS OF ONCOLOGY | 2007年 / 18卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：VII42 / VII42
页数：1
相关论文
共 50 条
  • [21] Chronomodulated Administration of Oxaliplatin plus Capecitabine (XELOX) as First Line Chemotherapy in Metastatic Colorectal Cancer Patients: Phase II Brunch Regimen Study.
    Pilanci, Kezban Nur
    Saglam, Sezer
    Okyar, Alper
    Yucel, Serap
    Kara, Zeliha Pala
    Ordu, Cetin
    Namal, Esat
    Ciftci, Rumeysa
    Koksal, Ulkuhan
    Saglam, Esra Kaytan
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [22] Phase II study of capecitabine plus oxaliplatin (XELOX) as first-line treatment and followed by maintenance of capecitabine in patients with metastatic colorectal cancer
    Li, Yu Hong
    Luo, Hui Yan
    Wang, Feng Hua
    Wang, Zhi Qiang
    Qiu, Miao Zhen
    Shi, Yan Xia
    Xiang, Xiao Juan
    Chen, Xiao Qing
    He, You Jian
    Xu, Rui Hua
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2010, 136 (04) : 503 - 510
  • [23] Phase II study of capecitabine plus oxaliplatin (XELOX) as first-line treatment and followed by maintenance of capecitabine in patients with metastatic colorectal cancer
    Yu Hong Li
    Hui Yan Luo
    Feng Hua Wang
    Zhi Qiang Wang
    Miao Zhen Qiu
    Yan Xia Shi
    Xiao Juan Xiang
    Xiao Qing Chen
    You Jian He
    Rui Hua Xu
    Journal of Cancer Research and Clinical Oncology, 2010, 136 : 503 - 510
  • [24] Pharmacogenetic approach for capecitabine or 5-fluorouracil selection to be combined with oxaliplatin as first-line chemotherapy in advanced colorectal cancer
    Martinez-Balibrea, Eva
    Abad, Albert
    Aranda, Enrique
    Sastre, Javier
    Manzano, Jose Luis
    Diaz-Rubio, Eduardo
    Gomez-Espana, Auxiliadora
    Aparicio, Jorge
    Garcia, Teresa
    Maestu, Inmaculada
    Martinez-Cardus, Anna
    Gines, Alba
    Guino, Elisabet
    EUROPEAN JOURNAL OF CANCER, 2008, 44 (09) : 1229 - 1237
  • [25] OXALIPLATIN PLUS CAPECITABINE (XELOX) AS FIRST-LINE CHEMOTHERAPY FOR ELDERLY PATIENTS WITH ADVANCED GASTRIC CANCER: RESULTS OF A MONOCENTRIC EXPERIENCE
    Rozzi, A.
    Corona, M.
    Nardoni, C.
    Restuccia, M.
    Lanzetta, G.
    ANNALS OF ONCOLOGY, 2009, 20 : 90 - 90
  • [26] Addition of SHR-1701 to first-line capecitabine and oxaliplatin (XELOX) plus bevacizumab for unresectable metastatic colorectal cancer
    Qiu, Miao-Zhen
    Bai, Yuxian
    Wang, Jufeng
    Gu, Kangsheng
    Yang, Mudan
    He, Yifu
    Yi, Cheng
    Jin, Yongdong
    Liu, Bo
    Wang, Feng
    Chen, Yu-kun
    Dai, Wei
    Jiang, Yingyi
    Huang, Chuanpei
    Xu, Rui-Hua
    Luo, Hui-Yan
    SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2024, 9 (01)
  • [27] Hepatectomy Followed by Adjuvant Chemotherapy with 3-Month Capecitabine Plus Oxaliplatin for Colorectal Cancer Liver Metastases
    Satake, Hironaga
    Hashida, Hiroki
    Tanioka, Hiroaki
    Miyake, Yasuhiro
    Yoshioka, Shinichi
    Watanabe, Takanori
    Matsuura, Masato
    Kyogoku, Takahisa
    Inukai, Michio
    Kotake, Takeshi
    Okita, Yoshihiro
    Matsumoto, Toshihiko
    Yasui, Hisateru
    Kotaka, Masahito
    Kato, Takeshi
    Kaihara, Satoshi
    Tsuji, Akihito
    ONCOLOGIST, 2021, 26 (07): : E1125 - E1132
  • [28] Retrospective analysis of capecitabine and oxaliplatin (XELOX) plus bevacizumab as a first-line treatment for Japanese patients with metastatic colorectal cancer
    Uchima, Yasutake
    Nishii, Takafumi
    Iseki, Yasuhito
    Ishii, Mariko
    Hiramatsu, Soichiro
    Iwauchi, Takehiko
    Morimoto, Junya
    Kosaka, Kinshi
    Tei, Seika
    Takeuchi, Kazuhiro
    MOLECULAR AND CLINICAL ONCOLOGY, 2014, 2 (01) : 134 - 138
  • [29] CAPECITABINE PLUS OXALIPLATIN (XELOX REGIMEN) A SAFE AND ACTIVE FIRST-LINE TREATMENT FOR CUBAN PATIENTS WITH METASTATIC COLORECTAL CANCER
    Lami, Leonardo
    Diaz, Carlos
    Areces, Fernando
    Lence, Juan
    Arbesu, Maria
    ANNALS OF ONCOLOGY, 2011, 22 : v95 - v96
  • [30] NEOADJUVANT CHEMOTHERAPY CAPECITABINE AND OXALIPLATIN (XELOX) COMBINED WITH BEVACIZUMAB FOR HIGH-RISK LOCALIZED RECTAL CANCER
    Takeshi, Kato
    Junichi, Hasegawa
    Tsunekazu, Mizushima
    Ho, Kim
    Yasuhiro, Miyake
    Taishi, Hata
    Junichi, Nishimura
    Kazumasa, Ikenaga
    Hiroyoshi, Takemoto
    Hiroshi, Tamagawa
    Shingo, Noura
    Masayuki, Ohue
    Kouhei, Murata
    Yuichiro, Fujie
    Mutsumi, Fukunaga
    Ichirou, Takemasa
    Masataka, Ikeda
    Hirofumi, Yamamoto
    Mistugu, Sekimoto
    Riichirou, Nezu
    Yuichiro, Doki
    Masaki, Mori
    ANNALS OF ONCOLOGY, 2014, 25 : 95 - 95
12345